<code id='669DDF7416'></code><style id='669DDF7416'></style>
    • <acronym id='669DDF7416'></acronym>
      <center id='669DDF7416'><center id='669DDF7416'><tfoot id='669DDF7416'></tfoot></center><abbr id='669DDF7416'><dir id='669DDF7416'><tfoot id='669DDF7416'></tfoot><noframes id='669DDF7416'>

    • <optgroup id='669DDF7416'><strike id='669DDF7416'><sup id='669DDF7416'></sup></strike><code id='669DDF7416'></code></optgroup>
        1. <b id='669DDF7416'><label id='669DDF7416'><select id='669DDF7416'><dt id='669DDF7416'><span id='669DDF7416'></span></dt></select></label></b><u id='669DDF7416'></u>
          <i id='669DDF7416'><strike id='669DDF7416'><tt id='669DDF7416'><pre id='669DDF7416'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:67219
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          5 to watch: Tech startups trying to solve health care's staffing crisis
          5 to watch: Tech startups trying to solve health care's staffing crisis

          AdobeThreeyearsafterthepandemicupendedthehealthcareworkforce,hospitalstaffingisstillatopconcernforho

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

          MollyFerguson/STATIwaswrongaboutGeron.Foryears,I’vebelieved—anddeclaredpublicly—thatGeron’sefforttod